Century Therapeutics to present CNTY-813 preclinical data at two fall congresses

July 9, 2026 8:00 AM

Century Therapeutics (NASDAQ: IPSC) announced that preclinical data for its CNTY-813 program have been accepted for oral presentations at two ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found